2014
DOI: 10.1016/j.autrev.2014.07.001
|View full text |Cite
|
Sign up to set email alerts
|

Obesity in autoimmune diseases: Not a passive bystander

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

16
499
5
11

Year Published

2015
2015
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 567 publications
(558 citation statements)
references
References 322 publications
16
499
5
11
Order By: Relevance
“…Visfatin, first detected in skeletal muscles, liver and bone marrow, is encoded by the PBEF1 gene [41]. It is secreted by visceral fat tissue [42] and is implicated in a number of conditions, such as aging, atherosclerosis, pathogenesis of type 2 diabetes and rheumatoid arthritis [43]. Its role in metabolic processes is still controversial, but it has been reported that the properties of visfatin are similar to insulin.…”
Section: Visfatinmentioning
confidence: 99%
“…Visfatin, first detected in skeletal muscles, liver and bone marrow, is encoded by the PBEF1 gene [41]. It is secreted by visceral fat tissue [42] and is implicated in a number of conditions, such as aging, atherosclerosis, pathogenesis of type 2 diabetes and rheumatoid arthritis [43]. Its role in metabolic processes is still controversial, but it has been reported that the properties of visfatin are similar to insulin.…”
Section: Visfatinmentioning
confidence: 99%
“…Not all psoriasis patients are obese and not all obese individuals develop psoriasis [4]. Although the above population studies related psoriasis to obesity, they miss assessing other environmental factors that may contribute to the onset of psoriasis such as; trauma, medications, infections, smoking, alcohol, stress or mental health disorders.…”
Section: Discussionmentioning
confidence: 99%
“…Further, obesity was found not only a risk of psoriasis (OR 1.48-6.46), but a major environmental factor contributing to the onset of autoimmune diseases such as rheumatoid arthritis (RA) (OR 1.2-3.4), multiple sclerosis (OR 2), and PsA (OR 1.48-6.46). It also worsens the course of RA, IBD, PsA and impairs the treatment response of RA, IBD, PsA, as well as psoriasis [4].…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations